Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer

被引:23
|
作者
Hirai, Y. [1 ,2 ]
Banno, K. [3 ]
Suzuki, M. [4 ]
Ichikawa, Y. [5 ]
Udagawa, Y. [6 ]
Sugano, K. [7 ]
Miki, Y. [8 ]
机构
[1] Japanese Fdn Canc Res, Inst Canc, Hosp Ariake, Dept Cytol,Koto Ku, Tokyo 1358550, Japan
[2] Japanese Fdn Canc Res, Inst Canc, Hosp Ariake, Dept Gynecol,Koto Ku, Tokyo 1358550, Japan
[3] Keio Univ, Dept Obstet & Gynecol, Fac Med, Tokyo 1608582, Japan
[4] Jichi Med Univ, Dept Obstet & Gynecol, Fac Med, Shimonoshi, Tochigi 3290498, Japan
[5] Kasumigaura Med Ctr, Dept Obstet & Gynecol, Tsuchiura, Ibaragi 3008585, Japan
[6] Fujita Hlth Univ, Dept Obstet & Gynecol, Fac Med, Aichi 4701192, Japan
[7] Tochigi Canc Ctr, Oncogene Res Lab, Utsunomiya, Tochigi 3200834, Japan
[8] Japanese Fdn Canc Res, Inst Canc, Dept Dent Diag, Koto Ku, Tokyo 1358550, Japan
关键词
D O I
10.1111/j.1349-7006.2008.00886.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, a high rate of endometrial cancer has been reported in women with hereditary non-polyposis colorectal cancer (HNPCC), suggesting a relationship between familial endometrial cancers and HNPCC. Familial endometrial cancers constitute only about 0.5% of all endometrial carcinomas and it is essential to examine family histories in detail. A mutational analysis of three DNA mismatch repair (MMR) genes (hMLH1, hMSH2 and hMSH6) in patients with endometrial cancer who meet our criteria for familial predisposition to HNPCC-associated endometrial cancers was performed. Mutations were detected in 18 of the 120 patients (15.0%). Most HNPCC-related endometrial cancers do not meet the New Amsterdam Criteria for HNPCC. These clinical criteria may identify only some HNPCC-associated endometrial cancers. Establishing the correct family history for endometrial cancer patients is important for diagnosing familial endometrial carcinomas. An analysis of MMR genes may be useful for patients with endometrial cancer showing familial aggregation. In addition, gynecologists must be accurately informed, and it is important to perform large-scale, multicenter studies both nationwide and internationally.
引用
收藏
页码:1715 / 1719
页数:5
相关论文
共 50 条
  • [21] Racial Difference in the Prevalence of DNA Mismatch Repair (MMR) Deficiencies Associated with Lynch Syndrome Among Patients with Colorectal Cancer
    Contino, Krysta
    Behling, Kathryn C.
    Edmonston, Tina
    Wang, Yize Richard
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S123 - S123
  • [22] INVESTIGATING THE RISK OF BLADDER CANCER AMONG HEREDITARY NON-POLYPOSIS COLORECTAL CANCER (HNPCC) PATIENTS WITH CONFIRMED MISMATCH REPAIR (MMR) GENE MUTATIONS
    Skeldon, S. C.
    Aronson, M.
    Semotiuk, K.
    Pollett, A.
    Van Rhijn, B. W. G.
    Bostrom, P. J.
    Gallinger, S.
    Cohen, Z.
    Fleshner, N. E.
    Jewett, M. A.
    Hanna, S.
    Kuk, C.
    Van Der Kwast, T. H.
    Evans, A.
    Bapat, B.
    Zlotta, A. R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 78 - 78
  • [23] LIFESTYLE MODIFIERS OF RISK OF ENDOMETRIAL CANCER FOR WOMEN WITH GERMLINE MUTATIONS IN DNA MISMATCH REPAIR GENES
    Win, A. K.
    Chau, R.
    Dashti, S. G.
    Ouakrim, D. Ait
    Buchanan, D.
    Clendenning, M.
    Casey, G.
    Gallinger, S.
    Haile, R. W.
    Le Marchand, L.
    Lindor, N. M.
    Newcomb, P. A.
    Hopper, J. L.
    Jenkins, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1577 - 1578
  • [24] Somatic tumor testing informs on mismatch repair deficiency (MMR-D) phenotype in patients with endometrial cancer
    Salib, M.
    Habib, H.
    Ebrahim, A. K. L. I. M.
    Shohdy, K. S.
    ANNALS OF ONCOLOGY, 2022, 33 : S393 - S393
  • [25] Rare variants in DNA damage repair genes are associated with male breast cancer predisposition
    Maguire, Sarah L.
    Tomczyk, Katarzyna
    Perrakis, Eleni
    Saunders, Edward
    Leongamornlert, Daniel
    Kote-Jarai, ZSofia
    Eeles, Rosalind
    Garcia-Closas, Montserrat
    Pharoah, Paul
    Easton, Douglas
    Lord, Christopher J.
    Ashworth, Alan
    Swerdlow, Anthony
    Orr, Nick
    CANCER RESEARCH, 2018, 78 (13)
  • [26] Mutational analysis of mismatch repair genes in Hereditary non-polyposis colon cancer.
    Lin-Goerke, J
    Wang, Y
    Ling, J
    Burczak, J
    Farrington, S
    Dunlop, M
    Robbins, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A72 - A72
  • [27] Detailed Analysis of the INSIGHT Global DNA Mismatch Repair (MMR) Gene Locus Specific Mutation Database (LDSB) and Familial Colorectal Cancer (CRC)
    Azarbayejani, A.
    Ady, J.
    Lai, V.
    Shin, J.
    Yuan, Z.
    Peltomaki, P.
    Moeslein, G.
    Macrae, F.
    Sas, D.
    White, N.
    Weber, T.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 15 - 15
  • [28] FAMILIAL DNA MISMATCH REPAIR CANCER PREDISPOSITION SYNDROMES ARE ASSOCIATED WITH A HIGH PREVALENCE OF DEVELOPMENTAL VENOUS ANOMALIES (DVA) OF THE BRAIN: A VASCULAR DEVELOPMENTAL DISORDER?
    Dvir, Rina
    Shiran, Shelly
    Ben-Sira, Liat
    Roth, Jonathan
    Tabori, Uri
    Bouffet, Eric
    Durno, Carol
    Aronson, Melyssa
    Constantini, Shlomi
    Elhasid, Ronit
    NEURO-ONCOLOGY, 2014, 16 : 124 - 124
  • [29] Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes
    Teng, Xu
    Yang, Tianshu
    Yuan, Baowen
    Yang, Yunkai
    Liu, Jiaxiang
    Wang, Xin
    Wang, Yong
    Ma, Tianyu
    Yin, Xin
    Yu, Hefen
    Wang, Shuang
    Huang, Wei
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [30] Copy number alterations of DNA mismatch repair (MMR) genes as novel prognostic markers in localised prostate cancer (CaP).
    Chua, Melvin
    Lalonde, Emilie
    Mahamud, Osman
    Berlin, Alejandro
    Dal Pra, Alan
    Orain, MichSle
    Picard, Valerie
    Hovington, Helene
    Bergeron, Alain
    Fradet, Yves
    Tetu, Bernard
    Meng, Alice
    Zhang, Junyan
    Zafarana, Gaetano
    Livingstone, Julie
    Pintilie, Melania
    van der Kwast, Theodorus
    Fraser, Michael
    Boutros, Paul
    Bristow, Robert G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)